Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 1928021, 11 pages
https://doi.org/10.1155/2017/1928021
Review Article

Prognostic Role of the MicroRNA-200 Family in Various Carcinomas: A Systematic Review and Meta-Analysis

1Department of Rehabilitation Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
2Department of Molecular Medicine and Tissue Injury Defense Research Center, Ewha Womans University School of Medicine, Seoul, Republic of Korea
3Division of Oncology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
4Cancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea

Correspondence should be addressed to Yoon Ho Ko; rk.ca.cilohtac@ohnooyok

Received 5 September 2016; Accepted 26 December 2016; Published 22 February 2017

Academic Editor: Lei Yao

Copyright © 2017 Jung Soo Lee et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. P. Bartel, “MicroRNAs: genomics, biogenesis, mechanism, and function,” Cell, vol. 116, no. 2, pp. 281–297, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. H.-W. Hwang and J. T. Mendell, “MicroRNAs in cell proliferation, cell death, and tumorigenesis,” British Journal of Cancer, vol. 94, no. 6, pp. 776–780, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. G. A. Calin, C. Sevignani, C. D. Dumitru et al., “Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 9, pp. 2999–3004, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. W. Kong, D. Ferland-McCollough, T. J. Jackson, and M. Bushell, “MicroRNAs in cancer management,” The Lancet Oncology, vol. 13, no. 6, pp. e249–e258, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Korpal and Y. Kang, “The emerging role of miR-200 family of microRNAs in epithelial-mesenchymal transition and cancer metastasis,” RNA Biology, vol. 5, no. 3, pp. 115–119, 2008. View at Google Scholar · View at Scopus
  6. B. P. Lewis, C. B. Burge, and D. P. Bartel, “Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets,” Cell, vol. 120, no. 1, pp. 15–20, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. P. S. Choi, L. Zakhary, W.-Y. Choi et al., “Members of the miRNA-200 family regulate olfactory neurogenesis,” Neuron, vol. 57, no. 1, pp. 41–55, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. B. Lu, J. J. Hu, W. J. Sun, X. H. Duan, and X. Chen, “Prognostic value of miR-141 downregulation in gastric cancer,” Genetics and Molecular Research, vol. 14, no. 4, pp. 17305–17311, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Yao, J. Hu, Z. Shen et al., “MiR-200b expression in breast cancer: a prognostic marker and act on cell proliferation and apoptosis by targeting Sp1,” Journal of Cellular and Molecular Medicine, vol. 19, no. 4, pp. 760–769, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Torres, K. Torres, A. Pesci et al., “Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients,” International Journal of Cancer, vol. 132, no. 7, pp. 1633–1645, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. Z.-M. Zhu, Y.-F. Xu, Q.-J. Su et al., “Prognostic significance of microRNA-141 expression and its tumor suppressor function in human pancreatic ductal adenocarcinoma,” Molecular and Cellular Biochemistry, vol. 388, no. 1-2, pp. 39–49, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Zhao, B. Wang, Y. Liu et al., “MiRNA-141, downregulated in pancreatic cancer, inhibits cell proliferation and invasion by directly targeting MAP4K4,” Molecular Cancer Therapeutics, vol. 12, no. 11, pp. 2569–2580, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Feng, J. Wang, M. Chen et al., “MiR-200a suppresses cell growth and migration by targeting MACC1 and predicts prognosis in hepatocellular carcinoma,” Oncology Reports, vol. 33, no. 2, pp. 713–720, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. B. Wang, M. Li, Z. Wu et al., “Associations between SOX2 and miR-200b expression with the clinicopathological characteristics and prognosis of patients with glioma,” Experimental and Therapeutic Medicine, vol. 10, no. 1, pp. 88–96, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. W. Zhu, J. He, D. Chen et al., “Expression of miR-29c, miR-93, and miR-429 as potential biomarkers for detection of early stage non-small lung cancer,” PLOS ONE, vol. 9, no. 2, Article ID e87780, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Berghmans, L. Ameye, L. Willems et al., “Identification of microRNA-based signatures for response and survival for non-small cell lung cancer treated with cisplatin-vinorelbine A ELCWP prospective study,” Lung Cancer, vol. 82, no. 2, pp. 340–345, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. L. Li, J. Tang, B. Zhang et al., “Epigenetic modification of MiR-429 promotes liver tumour-initiating cell properties by targeting Rb binding protein 4,” Gut, vol. 64, no. 1, pp. 156–167, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Zhao, Y. Zhao, Z. Wang, Y. Xuan, Y. Luo, and W. Jiao, “Loss expression of micro ribonucleic acid (miRNA)-200c induces adverse post-surgical prognosis of advanced stage non-small cell lung carcinoma and its potential relationship with ETAR messenger RNA,” Thoracic Cancer, vol. 6, no. 4, pp. 421–426, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. Q. Cao, K. Lu, S. Dai, Y. Hu, and W. Fan, “Clinicopathological and prognostic implications of the miR-200 family in patients with epithelial ovarian cancer,” International Journal of Clinical and Experimental Pathology, vol. 7, no. 5, pp. 2392–2401, 2014. View at Google Scholar · View at Scopus
  20. T. Diaz, R. Tejero, I. Moreno et al., “Role of miR-200 family members in survival of colorectal cancer patients treated with fluoropyrimidines,” Journal of Surgical Oncology, vol. 109, no. 7, pp. 676–683, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. M. K. Kim, S. B. Jung, J.-S. Kim et al., “Expression of microRNA miR-126 and miR-200c is associated with prognosis in patients with non-small cell lung cancer,” Virchows Archiv, vol. 465, no. 4, pp. 463–471, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Li, X. Li, S. Ren et al., “miR-200c overexpression is associated with better efficacy of EGFR-TKIs in non-small cell lung cancer patients with EGFR wild-type,” Oncotarget, vol. 5, no. 17, pp. 7902–7916, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Liu, Y. Ding, J. Huang et al., “MiR-141 suppresses the migration and invasion of HCC cells by targeting Tiam1,” PLoS ONE, vol. 9, no. 2, Article ID e88393, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. F. Song, D. Yang, B. Liu et al., “Integrated microRNA network analyses identify a poor-prognosis subtype of gastric cancer characterized by the miR-200 family,” Clinical Cancer Research, vol. 20, no. 4, pp. 878–889, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Tejero, A. Navarro, M. Campayo et al., “MiR-141 and miR-200c as markers of overall survival in early stage non-small cell lung cancer adenocarcinoma,” PLoS ONE, vol. 9, no. 7, Article ID e101899, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. J.-Q. Zhang, Q.-H. Yao, Y.-Q. Kuang et al., “Prognostic value of coexistence of abnormal expression of micro-RNA-200b and cyclic adenosine monophosphate-responsive element-binding protein 1 in human astrocytoma,” Human Pathology, vol. 45, no. 10, pp. 2154–2161, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. X.-Y. Huang, J.-G. Yao, H.-D. Huang et al., “MicroRNA-429 modulates hepatocellular carcinoma prognosis and tumorigenesis,” Gastroenterology Research and Practice, vol. 2013, Article ID 804128, 10 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Li, L. Du, Y. Yang et al., “MiR-429 is an independent prognostic factor in colorectal cancer and exerts its anti-apoptotic function by targeting SOX2,” Cancer Letters, vol. 329, no. 1, pp. 84–90, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. H. Tang, M. Deng, Y. Tang et al., “miR-200b and miR-200c as prognostic factors and mediators of gastric cancer cell progression,” Clinical Cancer Research, vol. 19, no. 20, pp. 5602–5612, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. F. Xiao, W. Zhang, L. Zhou et al., “MicroRNA-200a is an independent prognostic factor of hepatocellular carcinoma and induces cell cycle arrest by targeting CDK6,” Oncology Reports, vol. 30, no. 5, pp. 2203–2210, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Leskelä, L. J. Leandro-García, M. Mendiola et al., “The miR-200 family controls β-tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients,” Endocrine-Related Cancer, vol. 18, no. 1, pp. 85–95, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Marchini, D. Cavalieri, R. Fruscio et al., “Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections,” The Lancet Oncology, vol. 12, no. 3, pp. 273–285, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Yu, K. Ohuchida, K. Mizumoto et al., “MicroRNA, hsa-miR-200c, is an independent prognostic factor in pancreatic cancer and its upregulation inhibits pancreatic cancer invasion but increases cell proliferation,” Molecular Cancer, vol. 9, article 169, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Antolín, L. Calvo, M. Blanco-Calvo et al., “Circulating miR-200c and miR-141 and outcomes in patients with breast cancer,” BMC Cancer, vol. 15, no. 1, article 297, 2015. View at Publisher · View at Google Scholar · View at Scopus
  35. H.-M. Lin, L. Castillo, K. L. Mahon et al., “Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer,” British Journal of Cancer, vol. 110, no. 10, pp. 2462–2471, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Liu, J. Liu, L. Wang et al., “Association of serum microRNA expression in hepatocellular carcinomas treated with transarterial chemoembolization and patient survival,” PLoS ONE, vol. 9, no. 10, Article ID e109347, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. H. Yu, B. Duan, L. Jiang et al., “Serum miR-200c and clinical outcome of patients with advanced esophageal squamous cancer receiving platinum-based chemotherapy,” American Journal of Translational Research, vol. 6, no. 1, pp. 71–77, 2013. View at Google Scholar · View at Scopus
  38. K. Tanaka, H. Miyata, M. Yamasaki et al., “Circulating miR-200c levels significantly predict response to chemotherapy and prognosis of patients undergoing neoadjuvant chemotherapy for esophageal cancer,” Annals of Surgical Oncology, vol. 20, supplement 3, pp. S607–S615, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. Y. Toiyama, K. Hur, K. Tanaka et al., “Serum miR-200c is a novel prognostic and metastasis-predictive biomarker in patients with colorectal cancer,” Annals of Surgery, vol. 259, no. 4, pp. 735–743, 2014. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Valladares-Ayerbes, M. Reboredo, V. Medina-Villaamil et al., “Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer,” Journal of Translational Medicine, vol. 10, article 186, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. H. Cheng, L. Zhang, D. E. Cogdell et al., “Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis,” PLoS ONE, vol. 6, no. 3, Article ID e17745, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. A. Stang, “Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses,” European Journal of Epidemiology, vol. 25, no. 9, pp. 603–605, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Egger, G. D. Smith, M. Schneider, and C. Minder, “Bias in meta-analysis detected by a simple, graphical test,” British Medical Journal, vol. 315, no. 7109, pp. 629–634, 1997. View at Publisher · View at Google Scholar · View at Scopus
  44. J. Zhu, Z. Zheng, J. Wang et al., “Different miRNA expression profiles between human breast cancer tumors and serum,” Frontiers in Genetics, vol. 5, article 149, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. M. T. N. Le, P. Hamar, C. Guo et al., “MiR-200-containing extracellular vesicles promote breast cancer cell metastasis,” Journal of Clinical Investigation, vol. 124, no. 12, pp. 5109–5128, 2014. View at Publisher · View at Google Scholar · View at Scopus
  46. C. Shi and Z. Zhang, “The prognostic value of the miR-200 family in ovarian cancer: a meta-analysis,” Acta Obstetricia et Gynecologica Scandinavica, vol. 95, no. 5, pp. 505–512, 2016. View at Publisher · View at Google Scholar · View at Scopus
  47. J. Wu, Z. Fang, J. Xu, W. Zhu, Y. Li, and Y. Yu, “Prognostic value and clinicopathology significance of microrna-200c expression in cancer: a meta-analysis,” PLOS ONE, vol. 10, no. 6, Article ID e0128642, 2015. View at Publisher · View at Google Scholar · View at Scopus
  48. Y. Shimono, M. Zabala, R. W. Cho et al., “Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells,” Cell, vol. 138, no. 3, pp. 592–603, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. R. Hamano, H. Miyata, M. Yamasaki et al., “Overexpression of miR-200c induces chemoresistance in esophageal cancers mediated through activation of the Akt signaling pathway,” Clinical Cancer Research, vol. 17, no. 9, pp. 3029–3038, 2011. View at Publisher · View at Google Scholar · View at Scopus
  50. J. L. Bryant, J. Britson, J. M. Balko et al., “A microRNA gene expression signature predicts response to erlotinib in epithelial cancer cell lines and targets EMT,” British Journal of Cancer, vol. 106, no. 1, pp. 148–156, 2012. View at Publisher · View at Google Scholar · View at Scopus
  51. W. Zhu, H. Xu, D. Zhu et al., “miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP,” Cancer Chemotherapy and Pharmacology, vol. 69, no. 3, pp. 723–731, 2012. View at Publisher · View at Google Scholar · View at Scopus
  52. C. W. S. Kan, M. A. Hahn, G. B. Gard et al., “Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancer,” BMC Cancer, vol. 12, article 627, 2012. View at Publisher · View at Google Scholar · View at Scopus
  53. X.-G. Liu, W.-Y. Zhu, Y.-Y. Huang et al., “High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer,” Medical Oncology, vol. 29, no. 2, pp. 618–626, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. M. Tsujiura, D. Ichikawa, S. Komatsu et al., “Circulating microRNAs in plasma of patients with gastric cancers,” British Journal of Cancer, vol. 102, no. 7, pp. 1174–1179, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. X. Zhou, X. Wang, Z. Huang et al., “Prognostic value of miR-21 in various cancers: an updating meta-analysis,” PLoS ONE, vol. 9, no. 7, Article ID e102413, 2014. View at Publisher · View at Google Scholar · View at Scopus
  56. G.-H. Liu, Z.-G. Zhou, R. Chen et al., “Serum miR-21 and miR-92a as biomarkers in the diagnosis and prognosis of colorectal cancer,” Tumor Biology, vol. 34, no. 4, pp. 2175–2181, 2013. View at Publisher · View at Google Scholar · View at Scopus
  57. F. Wang, G. Long, C. Zhao et al., “Atherosclerosis-related circulating miRNAs as novel and sensitive predictors for acute myocardial infarction,” PLOS ONE, vol. 9, no. 9, Article ID e105734, 2014. View at Publisher · View at Google Scholar · View at Scopus